<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To examine an increased risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is restricted to patients who develop <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or whether <z:hpo ids='HP_0100633'>esophagitis</z:hpo> per se is a risk factor for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A population-based cohort of patients with histological evidence of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> without <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was constructed using electronic pathology reports relating to <z:hpo ids='HP_0000001'>all</z:hpo> esophageal biopsies in Northern Ireland between 1993 and 1996 </plain></SENT>
<SENT sid="2" pm="."><plain>Person-years of follow-up and incident cases of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> were calculated by linking the cohort to <z:hpo ids='HP_0011420'>death</z:hpo> files and the Northern Ireland <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Registry records </plain></SENT>
<SENT sid="3" pm="."><plain>Standardized incidence ratios (SIR) were calculated for <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> (<z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>), and histologically unspecified <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 2 013 patients in the cohort provided 13 559 patient-years of follow-up (mean follow-up 6.7 years) </plain></SENT>
<SENT sid="5" pm="."><plain>None of the patients developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Three patients developed <z:mp ids='MP_0004207'>SCC</z:mp>, and six developed histologically unspecified <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The SIR for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> and for <z:mp ids='MP_0004207'>SCC</z:mp> were 2.73 (95%CI 1.25-5.19) and 2.93 (95%CI 0.61-8.59), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>In a sensitivity analysis in which <z:hpo ids='HP_0000001'>all</z:hpo> unspecified <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> were treated as <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, the SIR for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> was 2.64 (0.97-5.75) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The risk of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is not elevated in patients with histological evidence of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> without <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>; however, these patients may have a moderately increased risk of <z:mp ids='MP_0004207'>SCC</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Further studies are required to confirm these findings, which suggest that <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, not <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, is the key precursor lesion in the development of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>